Best Practice’s Docs Medication Adherence to Oral Chemotherapy: Study on dasatinib

Texas Oncology is a privately owned company that provides intravenous and oral chemotherapy for cancer patients in 150 locations across Texas and Oklahoma. Dasatinib is one oral chemotherapy agent that is indicated fort the treatment of chronic myelogenous leukemia (ML) and acute lymphoblastic Leukemia (ALL) See entire chart by clicking link.

Discussion (0)

There are no comments for this doc yet.

Leave a Reply